… Amyloid-β oligomer-targeted gadolinium-based NIR/MR dual-modal theranostic
nanoprobe for Alzheimer's disease. Adv Funct Mater 2020;30(16):909529; doi: 10.1002/adfm.…

… cancer, neurodegeneration such as Alzheimer's disease, and pathogenic infections. … of
nucleic acids. However, their delivery remains a limiting factor for nucleic acid-based theranostics…

It is a very alarming situation for the globe because 55 million humans are estimated to be
affected by Alzheimer’s disease (AD) worldwide, and still it is increasing at the rapid speed of …

… Alzheimer’s disease is one of such diseases which, due to the limitations of our present
knowledge, remains uncurable while being the main cause of dementia in the elderly. The …

… disease prognosis and slow down disease progression. The development of nucleic acid-based …
To tackle these challenges, scientists have been actively exploring the potential of xeno …

… The findings of this study indicated potential application in curing neurological diseases
such as Parkinson's and Alzheimer's disease as well as spinocerebellar ataxia. …

… most exciting nucleic acid–based … Alzheimers disease. Since this seminal work, other studies
have been carried out on the role of exosomes in brain tumour and neurological disorders […

… skeletal disorders and used salicylic acid-based nanomedicine … [73] utilized ginger derived
nanoparticles (GDNPs) in theranostics… approach to tackling many metabolic disorders. The …

Alzheimer’s disease (AD) is the most prevalent form of dementia. It affects more than 30
million people worldwide and costs over US $1.3 trillion annually. AD is characterized by the …

… Nanotechnology and biology have the potential to tackle a wide range of biomedical problems
… Nucleic acid-based biosensors are prominently used as in a recent study; the plasmonic …